Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh $70.99

up +0.47


20/8/2014 12:25 PM  |  NYSE : AZN  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get AZN Trend Analysis - it has outperformed the S&P 500 by 21%

Partner Headlines

  1. Treasury Develolping Options to Curb Inversions

    FoxBusiness
  2. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  3. Drugmaker AstraZeneca Returns To Growth

    IBD
  4. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  5. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  6. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  7. Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition

    Benzinga
  8. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD
  9. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  10. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  11. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  12. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  13. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  14. I Believe AstraZeneca Is Fairly Valued

    GuruFocus
  15. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  16. British Blue Chips Beckon

    Benzinga
  17. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  18. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness
  19. Dow Trades Above 17,000 While S&P 500 Inches Closer To 2,000

    Benzinga
  20. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  21. S&P: Cut Corporate Taxes to Create 10M New Jobs

    FoxBusiness
  22. Rumor Of Massive Monsanto-Syngenta Deal Gets Agriculture Sector Moving

    Benzinga
  23. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  24. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  25. Medtronic to Buy Covidien for $42.0 Billion

    FoxBusiness
  26. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  27. Morning Market Movers

    Benzinga
  28. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  29. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga
  30. M&A Activity Fearless Against Rate Hikes

    FoxBusiness
  31. AstraZeneca sees deal hurdles

    IBD
  32. A Bitter Pill

    FoxBusiness
  33. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals ...

    Benzinga
  34. Allergan May Get Higher Bid

    IBD
  35. Market Wrap For May 13: Markets Close Again At Record Highs

    Benzinga
  36. AstraZeneca Would Weigh Strong Pfizer Offer

    FoxBusiness
  37. 7 Stocks For Your Retirement Portfolio

    Benzinga
  38. Wall Street Edges Up, Builds on Record Highs

    FoxBusiness
  39. Stock Futures Up Ahead of Retail Sales Reading

    FoxBusiness
  40. Allergan Rejects Valeant Bid

    IBD
  41. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  42. Pfizer Defends AstraZeneca Deal

    FoxBusiness
  43. Benzinga's Weekend M&A Chatter

    Benzinga
  44. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  45. Defensive Stocks In Spotlight

    IBD
  46. Amgen

    IBD
  47. Pfizer getting heat over buyout

    IBD
  48. Horizon guides '14 sales up

    IBD
  49. Can Pfizer Make Up Its Loss?

    GuruFocus
  50. Will The U.K.'s Business Department Block Pfizer's Bid?

    Benzinga
Trading Center